Articles

This Newborn Screening Awareness Month, learn how updated ARUP Consult^® topics support clinicians with evidence-based recommendations for diagnostic testing, monitoring, and genetic testing.

ARUP researchers, including (left to right) Danielle LaGrave, MS, LCGC, Lauren Wallace, MS, LCGC, and Katie Rudd, PhD, FACMG, have investigated the connection between atypical cell-free DNA screening results and diagnostic findings. (Not pictured: Rebekah Whitham, BS, MA, and Hannah S. Anderson, MS, LCGC)

When a lone star tick bites a person, it can transfer alpha-gal into the person’s bloodstream, leading to the development of anti-alpha-gal antibodies. These antibodies can trigger an allergic reaction to red meat, or according to a new study, a reaction to a blood transfusion in some patients.

Jonathan Genzen, MD, PhD, MBA, ARUP chief medical officer and senior director of government affairs, explores key provisions of the Enhancing CLIA Act in a seven-part article series on LinkedIn to help inform the discussion around future oversight of laboratory-developed tests.

Attendees will have the unique opportunity to tour ARUP Laboratories during the 2026 AMLI Annual Meeting.

ARUP Laboratories observed Cyclospora positivity rates increase from very low levels to unprecedented levels within a short period of time, highlighting the importance of providing clinicians and laboratorians with timely disease surveillance data, said Ben Bradley, MD, PhD, ARUP head of clinical operations for Infectious Disease.

ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry characterizes small neoplastic populations with greater sensitivity than conventional flow cytometry while requiring less specimen volume.

Visit ARUP at booth #4453 to learn more about what’s happening at the forefront of laboratory medicine, speak with our experts, and test your skills at parasite and blood cell identification.

Cyclospora are notoriously difficult to detect by traditional microscopy methods. ARUP offers robust, artificial intelligence (AI)-enhanced testing that can help providers diagnose cyclosporiasis and respond to current outbreaks.

Karen Brisendine (left) and ARUP CEO Andy Theurer celebrate Karen’s retirement after 42 years with the company. Karen is the last of ARUP’s original 100 employees to retire.

Salt Lake City Mayor Erin Mendenhall (left) presents 2-year-old Calvin with a key to the city as part of a Make-A-Wish^® Utah event that began for Calvin in the Advanced Practice Clinical Lab at ARUP.